Browse > Article
http://dx.doi.org/10.5012/bkcs.2010.31.8.2180

Antiviral Activity Enhancement through the SATE Prodrug of a 2'-Modified 5'-Norcarbocyclic Adenine Analogue  

Li, Hua (BK-21 Project Team, College of Pharmacy, Chosun University)
Kim, Si-Wouk (Department of Environmental Engineering, BK21 Team for Biohydrogen Production, Chosun University)
Hong, Joon-Hee (BK-21 Project Team, College of Pharmacy, Chosun University)
Publication Information
Bulletin of the Korean Chemical Society / v.31, no.8, 2010 , pp. 2180-2184 More about this Journal
Abstract
We synthesized and tested the anti-HIV activity of the SATE prodrug of a 2'-methyl 5'-norcarbocyclic adenine analogue. The introduction of a methyl group in the 2'-position was performed by the addition of a carbonyl using isopropenyl magnesium bromide. The adenine base was efficiently coupled using the Mitsunobu reaction. The chemical stability study of the bis(SATE) derivative 18 was measured at neutral (pH 7.2) and slightly acid (milli-Q water, pH 5.5) pH, and compounds 16 and 18 were evaluated as potential anti-HIV-1 agents.
Keywords
Antiviral agent; Carbocyclic nucleoside; SATE prodrug; Phosphonic acid;
Citations & Related Records

Times Cited By Web Of Science : 2  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 El-Subbagh, H. I.; Racha, S.; Abushanab, E.; Panzica, R. P. J. Org. Chem. 1996, 61, 890.   DOI
2 Nylen, P.; Olsen, A. Svensk, Kem. Tidsk. 1941, 53, 274.
3 Lefebvre, I.; Perigaud, C.; Pompon, A.; Aubertin, A. M.; Girardet, J. L.; Kirn, A.; Gosselin, G.; Imbach, J. L. J. Med. Chem. 1995, 38, 3941.   DOI
4 Perigaud, C.; Gosselin, G.; Lefebvre, I.; Girardet, J. L.; Benzaria, S.; Barber, I.; Imbach, J. L. Bioorg. Med. Chem. Lett. 1993, 3, 2521.   DOI   ScienceOn
5 Furstner, A. Angew. Chem. Int. Ed. 2000, 39, 3012.   DOI
6 Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Angew. Chem. Int. Ed. 2005, 44, 4490.   DOI
7 Kim, A.; Oh, C. H.; Hong, J. H. Nucleosides, Nucleotides Nucleic Acids 2006, 25, 1399.   DOI
8 Hansen, E. C.; Lee, D. Acc. Chem. Res. 2006, 39, 509.   DOI
9 Michel, B. Y.; Strazewski, P. Tetrahedron 2007, 63, 9836.   DOI
10 Tanaka, M.; Norimine, Y.; Fujita, T.; Suemune, H.; Sakai, K. J. Org. Chem. 1996, 61, 6952.   DOI
11 Kim, A.; Hong, J. H. Nucleosides, Nucleotides Nucleic Acids 2006, 25, 1.   DOI
12 Mackman, R. L.; Boojamra, C. G.; Prasad, V.; Zhang, L.; Lin, K. Y.; Petrakovsky, O.; Babusis, D.; Chen, J.; Douglas, J.; Grant, D.; Hui, H. C.; Kim, C. U.; Markevitch, D. Y.; Vela, J.; Ray, A.; Cihlar, T. Bioorg. Med. Chem. Lett. 2007, 17, 6785.   DOI
13 Boojamra, C. G.; Mackman, R. L.; Markevitch, D.Y.; Prasad, V.; Ray, A. S.; Douglas, J.; Grant, D.; Kim, C. U.; Cihlar, T. Bioorg. Med. Chem. Lett. 2008, 18, 1120.   DOI
14 Benzaria, S.; Pélicano, H.; Johnson, R.; Maury, G.; Imbach, J. L.; Aubertin, A. M.; Obert, G.; Gosselin, G. J. Med. Chem. 1996, 39, 4958.   DOI
15 Mackman, R. L.; Lin, K. Y.; Boojamra, C. G.; Hui, H.; Douglas, J.; Grant, D.; Petrakovsky, O.; Prasad, V.; Ray, A. S.; Cihlar, T. Bioorg. Med. Chem. Lett. 2008, 18, 1116.   DOI
16 Jones, R. J.; Bischofberger, N. Antiviral Res. 1995, 27, 1.   DOI
17 Srinivas, R. V.; Robbins, B. L.; Connelly, M. C.; Gong, Y. F.; Bischofberger, N.; Fridland, A. Antimicrob. Agents Chemother. 1993, 37, 2247.   DOI
18 Palu, G.; Stefanelli, S.; Rassu, M.; Parolin, C.; Balzarini, J.; De Clercq, E. Antiviral Res. 1991, 16, 115.   DOI
19 Naesens, L.; Balzarini, J.; De Clercq, E. Med. Virol. 1994, 4, 147.   DOI
20 Yin, X. Q.; Li, W. K.; Yang, M.; Schneller, S. W. Bioorg. Med. Chem. 2009, 17, 3126.   DOI
21 Sisu, E.; Sollogoub, M.; Mallet, J. M.; Sinay, P. Tetrahedron 2002, 58, 10189.   DOI
22 Zemlicka, J.; Gasser, R.; Freisler, J. V.; Horwitz, J. P. J. Am. Chem. Soc. 1972, 94, 3213.   DOI
23 De Clercq, E. Int. J. Antimicrob. Agents 1999, 112, 81.
24 De Clercq, E. Med. Res. Rev. 2002, 22, 531   DOI   ScienceOn
25 Katagiri, N.; Nomura, M.; Sato, H.; Kaneko, C.; Yusa, K.; Tsuruo, T. J. Med. Chem. 1992, 35, 1882.   DOI